# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-005017
Filing Date
2023-01-19
Accepted
2023-01-19 16:18:58
Documents
50

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | tm2227887-17_424b3.htm | 424B3 | 9726235
2 | GRAPHIC | lg_sesenbio-4c.jpg | GRAPHIC | 36236
3 | GRAPHIC | lg_carismatherapeutics-4c.jpg | GRAPHIC | 74061
4 | GRAPHIC | lg_mackenziepartners-bw.jpg | GRAPHIC | 37031
5 | GRAPHIC | tm2227887d8-tbl_pipelin4c.jpg | GRAPHIC | 195984
6 | GRAPHIC | tm2227887d8-tbl_oncolog4c.jpg | GRAPHIC | 225662
7 | GRAPHIC | tm2227887d8-fc_problem4c.jpg | GRAPHIC | 513116
8 | GRAPHIC | tm2227887d1-pht_tumor4c.jpg | GRAPHIC | 379411
9 | GRAPHIC | tm2227887d1-lc_human4c.jpg | GRAPHIC | 170334
10 | GRAPHIC | tm2227887d4-lc_contrl4c.jpg | GRAPHIC | 138291
11 | GRAPHIC | tm2227887d4-lc_reprogra4c.jpg | GRAPHIC | 382732
12 | GRAPHIC | tm2227887d1-pht_macrop4clr.jpg | GRAPHIC | 401401
13 | GRAPHIC | tm2227887d1-tbl_exvivo4c.jpg | GRAPHIC | 256191
14 | GRAPHIC | tm2227887d4-tbl_pipelin4c.jpg | GRAPHIC | 154647
15 | GRAPHIC | tm2227887d1-pht_key4c.jpg | GRAPHIC | 81013
16 | GRAPHIC | tm2227887d1-org_clinic4c.jpg | GRAPHIC | 345160
17 | GRAPHIC | tm2227887d4-bc_adverse4c.jpg | GRAPHIC | 192481
18 | GRAPHIC | tm2227887d4-lc_rapidly4c.jpg | GRAPHIC | 224160
19 | GRAPHIC | tm2227887d1-bc_single4clr.jpg | GRAPHIC | 117714
20 | GRAPHIC | tm2227887d4-bc_mostpreva4c.jpg | GRAPHIC | 205062
21 | GRAPHIC | tm2227887d4-bc_frequen4c.jpg | GRAPHIC | 151051
22 | GRAPHIC | tm2227887d4-tbl_selct4c.jpg | GRAPHIC | 268796
23 | GRAPHIC | tm2227887d4-lc_pt4comp4c.jpg | GRAPHIC | 199529
24 | GRAPHIC | tm2227887d1-lc_asses4c.jpg | GRAPHIC | 240932
25 | GRAPHIC | tm2227887d1-lc_itcar4c.jpg | GRAPHIC | 97783
26 | GRAPHIC | tm2227887d1-pht_profnd4clr.jpg | GRAPHIC | 966559
27 | GRAPHIC | tm2227887d1-bc_119ct4c.jpg | GRAPHIC | 197496
28 | GRAPHIC | tm2227887d4-lc_ct1119a5494c.jpg | GRAPHIC | 127410
29 | GRAPHIC | tm2227887d1-lc_carmno4c.jpg | GRAPHIC | 357153
30 | GRAPHIC | tm2227887d1-bc_cyto4c.jpg | GRAPHIC | 570422
31 | GRAPHIC | tm2227887d1-lc_polar4c.jpg | GRAPHIC | 162437
32 | GRAPHIC | tm2227887d4-lc_persis4c.jpg | GRAPHIC | 331405
33 | GRAPHIC | tm2227887d4-lc_tumor4c.jpg | GRAPHIC | 199519
34 | GRAPHIC | tm2227887d4-fc_antibody4c.jpg | GRAPHIC | 333401
35 | GRAPHIC | tm2227887d1-lc_poten4c.jpg | GRAPHIC | 163450
36 | GRAPHIC | tm2227887d1-pht_ipsc4clr.jpg | GRAPHIC | 325874
37 | GRAPHIC | tm2227887d1-bc_icar4c.jpg | GRAPHIC | 146105
38 | GRAPHIC | tm2227887d4-lc_ipscmacs4c.jpg | GRAPHIC | 235648
39 | GRAPHIC | tm2227887d1-pht_myloid4clr.jpg | GRAPHIC | 538993
40 | GRAPHIC | tm2227887d4-lc_lnp4c.jpg | GRAPHIC | 123230
41 | GRAPHIC | tm2227887d4-lc_2lnp4c.jpg | GRAPHIC | 119912
42 | GRAPHIC | tm2227887d4-lc_3lnp4c.jpg | GRAPHIC | 143217
43 | GRAPHIC | tm2227887d4-lc_4lnp4c.jpg | GRAPHIC | 120161
44 | GRAPHIC | tm2227887d4-lc_5lnp4c.jpg | GRAPHIC | 117668
45 | GRAPHIC | tm2227887d4-lc_6lnp4c.jpg | GRAPHIC | 142432
46 | GRAPHIC | tm2227887d1-pht_reprobw.jpg | GRAPHIC | 241333
47 | GRAPHIC | tm2227887d1-lc_macro4c.jpg | GRAPHIC | 247139
48 | GRAPHIC | tm2227887d4-fc_carm4c.jpg | GRAPHIC | 183946
49 | GRAPHIC | lg_svbsecurities-4c.jpg | GRAPHIC | 43020
50 | GRAPHIC | ft_svbsecurities-4c.jpg | GRAPHIC | 57819
| Complete submission text file | 0001104659-23-005017.txt |  | 24801909

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267891 | Film No.: 23537638
SIC: 2834 Pharmaceutical Preparations